AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
+8.66%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$2.51B
AUM Growth
+$2.51B
(+17%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
89.42%
Holding
45
New
1
Increased
3
Reduced
5
Closed
2
Top Buys
| 1 |
GitLab
GTLB
|
$415M |
| 2 |
Freshworks
FRSH
|
$151M |
| 3 |
Prime Medicine
PRME
|
$22.4M |
| 4 |
Fractyl Health
GUTS
|
$4.9M |
Top Sells
| 1 |
DexCom
DXCM
|
$262M |
| 2 |
CrowdStrike
CRWD
|
$137M |
| 3 |
Oscar Health
OSCR
|
$17.1M |
| 4 |
Neumora Therapeutics
NMRA
|
$6.9M |
| 5 |
Invivyd
IVVD
|
$5.12M |
Sector Composition
| 1 | Technology | 62.03% |
| 2 | Healthcare | 34.22% |
| 3 | Industrials | 3.63% |
| 4 | Consumer Staples | 0.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GitLab
GTLB
$7.93B
| $569M | 22.64% | 9,758,333 +7,111,021 | +269% | +$415M |
|
|
2
CrowdStrike
CRWD
$106B
| $274M | 10.91% | 855,789 -427,894 | -33% | -$137M |
|
|
3
DexCom
DXCM
$29.5B
| $248M | 9.88% | 1,790,773 -1,891,112 | -51% | -$262M |
|
4
Arm
ARM
$147B
| $245M | 9.75% | 1,960,784 | – | – |
|
|
5
Freshworks
FRSH
$3.93B
| $225M | 8.94% | 12,336,643 +8,301,048 | +206% | +$151M |
|
6
Revolution Medicines
RVMD
$7.1B
| $171M | 6.8% | 5,301,512 | – | – |
|
|
VERV
7
DELISTED
Verve Therapeutics
VERV
| $164M | 6.52% | 12,349,086 | – | – |
|
8
UiPath
PATH
$5.95B
| $159M | 6.34% | 7,034,337 | – | – |
|
|
9
Prime Medicine
PRME
$578M
| $105M | 4.19% | 15,062,498 +3,200,000 | +27% | +$22.4M |
|
10
Snowflake
SNOW
$79.6B
| $86.6M | 3.44% | 535,604 | – | – |
|
11
Planet Labs
PL
$2.15B
| $81.5M | 3.24% | 31,942,641 | – | – |
|
12
Sana Biotechnology
SANA
$777M
| $28.1M | 1.12% | 2,812,500 | – | – |
|
|
13
Invivyd
IVVD
$204M
| $20.1M | 0.8% | 4,527,122 -1,153,663 | -20% | -$5.12M |
|
14
Lyell Immunopharma
LYEL
$213M
| $13.1M | 0.52% | 5,865,125 | – | – |
|
15
Relay Therapeutics
RLAY
$619M
| $13M | 0.52% | 1,568,753 | – | – |
|
16
Beam Therapeutics
BEAM
$1.66B
| $10.6M | 0.42% | 321,604 | – | – |
|
17
Vera Therapeutics
VERA
$1.38B
| $10.4M | 0.41% | 241,264 -60,316 | -20% | -$2.6M |
|
18
Monte Rosa Therapeutics
GLUE
$296M
| $10.3M | 0.41% | 1,464,015 | – | – |
|
|
DM
19
DELISTED
Desktop Metal, Inc.
DM
| $9.72M | 0.39% | 11,048,730 | – | – |
|
20
TScan Therapeutics
TCRX
$102M
| $8.55M | 0.34% | 1,077,080 | – | – |
|
21
Illumina
ILMN
$15.8B
| $7.34M | 0.29% | 53,470 | – | – |
|
|
22
Oscar Health
OSCR
$4.31B
| $7.17M | 0.29% | 481,988 -1,147,099 | -70% | -$17.1M |
|
23
Dianthus Therapeutics
DNTH
$759M
| $6.26M | 0.25% | 208,697 | – | – |
|
|
24
Fractyl Health
GUTS
$68.8M
| $4.9M | 0.2% | +662,584 | New | +$4.9M |
|
25
RAPT Therapeutics
RAPT
$188M
| $4.85M | 0.19% | 540,270 | – | – |
|